A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

ABT-122

Injection

BIOLOGICAL

Placebo

Placebo Injection

Trial Locations (4)

Site Reference ID/Investigator# 118964, Duncansville

Site Reference ID/Investigator# 107115, Raleigh

Site Reference ID/Investigator# 108655, Lenexa

Site Reference ID/Investigator# 100780, Dallas